Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M C Perry

Showing results (101-110 of 151) with videos related to

Pageof 16
Sort By:
Southern Medical Journal|September 1, 1988
Hematologic effects of heavy metal poisoningQ S Ringenberg, D C Doll, W P Patterson, et al.
Mayo Clinic Proceedings|January 1, 1991
Hemoglobin Columbia Missouri or alpha 2[88 (F9) Ala----Val]beta 2: a new high-oxygen-affinity hemoglobin that causes erythrocytosisM C Perry, C Head, V F Fairbanks, et al.
Cancer Treatment Reports|September 1, 1976
Phase II studies of dianhydrogalactitol and VP-16-213 in colorectal cancerM C Perry, C G Moertel, A J Schutt, et al.
Missouri Medicine|February 1, 1989
Survey of cancer control attitudes among Missouri state legislatorsJ R Davis, T G Kern, M C Perry, et al.
Cancer Clinical Trials|January 1, 1979
Adriamycin and cis-dichlorodiammineplatinum in nonresectable and metastatic carcinoma of the lungR W Morris, L H Brubaker, C G Kardinal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 20, 2009
Gemcitabine and pemetrexed administered in rapid sequence as front-line chemotherapy for advanced non-small-cell lung cancer: a phase II clinical trialH L West, H A Wakelee, M C Perry, et al.
Digestive Diseases and Sciences|December 1, 1989
Autonomic function and motility in intestinal pseudoobstruction caused by paraneoplastic syndromeN Sodhi, M Camilleri, J K Camoriano, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|September 3, 1998
A study of filgrastim (rG-CSF) priming of etoposide/cisplatin in advanced non-small cell lung cancerS A Mehdi, M C Perry, J E Herndon, et al.
Cancer|February 1, 1988
Responses to chemotherapy or chemohormonal therapy in advanced breast cancer patients treated previously with adjuvant chemotherapy. A subset analysis of CALGB Study 8081C G Kardinal, M C Perry, A H Korzun, et al.
Seminars in Oncology|August 1, 1997
A phase II study evaluating the efficacy of carboplatin, etoposide, and paclitaxel with granulocyte colony-stimulating factor in patients with stage IIIB and IV non-small cell lung cancer and extensive small cell lung cancerH B Neill, A A Miller, G H Clamon, et al.
Pageof 16

Showing results (101-110 of 151) with videos related to

Sort By:
Pageof 16
Southern Medical Journal|September 1, 1988
Hematologic effects of heavy metal poisoningQ S Ringenberg, D C Doll, W P Patterson, et al.
Mayo Clinic Proceedings|January 1, 1991
Hemoglobin Columbia Missouri or alpha 2[88 (F9) Ala----Val]beta 2: a new high-oxygen-affinity hemoglobin that causes erythrocytosisM C Perry, C Head, V F Fairbanks, et al.
Cancer Treatment Reports|September 1, 1976
Phase II studies of dianhydrogalactitol and VP-16-213 in colorectal cancerM C Perry, C G Moertel, A J Schutt, et al.
Missouri Medicine|February 1, 1989
Survey of cancer control attitudes among Missouri state legislatorsJ R Davis, T G Kern, M C Perry, et al.
Cancer Clinical Trials|January 1, 1979
Adriamycin and cis-dichlorodiammineplatinum in nonresectable and metastatic carcinoma of the lungR W Morris, L H Brubaker, C G Kardinal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 20, 2009
Gemcitabine and pemetrexed administered in rapid sequence as front-line chemotherapy for advanced non-small-cell lung cancer: a phase II clinical trialH L West, H A Wakelee, M C Perry, et al.
Digestive Diseases and Sciences|December 1, 1989
Autonomic function and motility in intestinal pseudoobstruction caused by paraneoplastic syndromeN Sodhi, M Camilleri, J K Camoriano, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|September 3, 1998
A study of filgrastim (rG-CSF) priming of etoposide/cisplatin in advanced non-small cell lung cancerS A Mehdi, M C Perry, J E Herndon, et al.
Cancer|February 1, 1988
Responses to chemotherapy or chemohormonal therapy in advanced breast cancer patients treated previously with adjuvant chemotherapy. A subset analysis of CALGB Study 8081C G Kardinal, M C Perry, A H Korzun, et al.
Seminars in Oncology|August 1, 1997
A phase II study evaluating the efficacy of carboplatin, etoposide, and paclitaxel with granulocyte colony-stimulating factor in patients with stage IIIB and IV non-small cell lung cancer and extensive small cell lung cancerH B Neill, A A Miller, G H Clamon, et al.
Pageof 16